Torrent Pharmaceuticals has announced a board meeting scheduled for November 7, 2025. The board will review and approve the audited financial results on a standalone basis, as well as the unaudited financial results with limited review, on a consolidated basis. These results are for the quarter and half-year ending September 30, 2025.
Board Meeting Announcement
Torrent Pharmaceuticals has scheduled a meeting of its Board of Directors to be held on Friday, November 7, 2025. During this meeting, the board will address key financial matters for the company.
Financial Results on the Agenda
The primary focus of the meeting will be the review and potential approval of the company’s financial performance. Specifically, the board will consider the following:
Audited Standalone Financial Results: These results will reflect the company’s performance as an individual entity.
Unaudited Consolidated Financial Results: These results will offer a comprehensive view of the Torrent Group’s financial standing, incorporating all its subsidiaries and associated entities. These results will undergo a limited review.
Reporting Period
The financial results under consideration pertain to the quarter and half-year period concluding on September 30, 2025. This corresponds to Q2 (July-September) of the Indian financial year.
Source: BSE